Samuel U. Takvorian, MD, MS

Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West
View 1 additional location
Headshot of Samuel U. Takvorian, MD, MS
Penn Medicine Provider

About me

  • Assistant Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania

My education and training

  • Medical School: Harvard Medical School
  • Residency: Massachusetts General Hospital/Brigham and Women’s Hospital
  • Fellowship: University of Pennsylvania Health System

Spoken languages

English
English

Reviews

Average Rating

848 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
August 2026
again, he is clearly a caretaker of those he is seeing
Anonymous
August 2026
dr takvorian was very thorough and helpful
Anonymous
August 2026
thorough, knowledgeable, comforting
Anonymous
August 2026
good and understandable

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Takvorian is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Pepin A, Doucette A, Narayan VK, Maxwell KN, Takvorian SU, O'Brien SR, Mankoff DA, Mulugeta PG, Taunk NK. Differential Response to (177)Lu-PSMA-617 in Patients with Tumor Suppressor Gene-Mutated Metastatic Castration-Resistant Prostate Cancer , J Nucl Med, 67(6): 2026,926-928.


Crawford TB, Tayeb M, Barrett E, Al-Saleem T, Kondam P, Hausler R, Symecko H, Orr C, Wolfe CS, Mann D, Spielman K, Wong G, Haas NB, Narayan V, Robinson K, Takvorian S, Wong YN, Sokolova AO, Montgomery RB, Menendez C, Kelley MJ, Aiello LB, Garraway IP, Domchek SM, Maxwell KN. Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patients With Prostate Cancer , J Natl Compr Canc Netw, 24(7): 2026,e267006.


Song W, Saia C, Wainwright J, Kalman J, Toneff H, Takvorian SU, Rendle KA. Understanding patient engagement with an oncology chatbot: Thematic and sentiment analysis of medical adherence. , American Society of Clinical Oncology Annual Meeting, Chicago, IL. , 44(16): 2026


Aleixo G, Ani J, Ferrell WJ, Malik S, Peters S, Adams, Loreg M, Eckert A, Grant D, Perloff T, Syed M, Parikh RB, Gabriel P, Hughes S, Dotan E, Sedhom R, Takvorian SU. Practical Geriatric Assessment (PGA) Implementation Strategies and Correlative Evaluations (PACE-70): Protocol for a hybrid implementation-effectiveness study in three community oncology practices in the United States , J Geriatr Oncol, 17(4): 2026,102965.


Litt HK, Wodzinski A, Subramanian P, Donovan M, Vapiwala N, Narayan V, Mei L, Takvorian S, Haas NB, Parikh RB, Mistry R, Mamtani R. OncoEducate: A Pilot Study of Generative AI to Enhance Patient-Clinician Communication in Genitourinary Cancer Care , Oncologist, 31(5): 2026,oyag135.


Litt HK, Wodzinski A, Subramanian P, Donovan M, Vapiwala N, Parikh RB, Narayan V, Mei L, Takvorian SU, Balzer Haas N, Mistry R, and Mamtani R. OncoEducate: A pilot study of generative AI to support patient education in GU cancer care. , 2026 American Society of Clinical Oncology Genitourinary Cancers Symposium, San Fransisco, CA., 44(7): 2026,713


Mo G, Maier S, Doyle M, Sweeney S, Orellana J, Farago L, Lloyd A, Mawema H, Bajaj A, Mei L, Takvorian SU, Haas NB, Ky B, Leong D, Narayan V. Cardiovascular risk evaluation in men with prostate cancer study (CARE-PC): Pilot study to assess patient awareness and risk mitigation. , 2026 American Society of Clinical Oncology Genitourinary Cancers Symposium, San Fransisco, CA. : 2026


Aleixo G, Ani J, Raghavendran K, Zuber C, Goldman N, Gabriel P, Singh A, Boisseau L, Takvorian S, Dougherty D, Dotan E, Sedhom R. Embedding Geriatric Oncology in a Community Practice of an Academic Health System: Implementation, Outcomes, and End-of-Life Impact , JCO Oncol Pract: 2026,OP2500772.


Pepin A, Doucette A, Vapiwala N, Narayan VK, Takvorian SU, O'Brien SR, Mankoff DA, Mulugeta P, Taunk NK. Safety of the Combination of External Beam Radiotherapy with 177Lu-PSMA-617 in Patients with Metastatic Castrate Resistant Prostate Cancer (mCRPC) , J Nucl Med, 66(12): 2025,1927-1933.


Crawford TB, Tayeb M, Barrett E, Al-Saleem T, Kondam P, Hausler R, Symecko H, Orr C, Wolfe C, Mann D, Spielman K, Wong G, Haas N, Narayan V, Robinson K, Takvorian S, Wong YN, Sokolova A, Montgomery RB, Menendez C, Kelley MJ, Aiello LB, Garraway IP, Domchek SM, Maxwell KN. Pathogenic germline variants in a racially diverse real-world cohort of prostate cancer patients , J Natl Compr Canc Netw.: 2025,15:2025.08.13.25333614.


View all publications